Radiofrequency Ablation of Liver Cancer: A Review
Author Information
Author(s): Minami Yasunori, Kudo Masatoshi
Primary Institution: Department of Gastroenterology and Hepatology, School of Medicine, Kinki University
Hypothesis
Can radiofrequency ablation (RFA) provide effective treatment for hepatocellular carcinoma (HCC)?
Conclusion
Radiofrequency ablation can achieve similar survival rates to surgical resection for small HCC while causing fewer side effects.
Supporting Evidence
- RFA achieved survival rates similar to those achieved by surgical resection.
- Local recurrence rates after RFA for HCC ranged from 1.7% to 41%.
- RFA combined with transcatheter arterial chemoembolization (TACE) improves outcomes for larger tumors.
Takeaway
Doctors can use a special heat treatment called radiofrequency ablation to help patients with liver cancer, and it works just as well as surgery for small tumors.
Methodology
The review summarizes evidence from cohort series and randomized controlled trials comparing RFA to surgical resection.
Potential Biases
Potential bias in reporting outcomes from different studies.
Limitations
The review may not cover all recent advancements in RFA techniques and outcomes.
Participant Demographics
Patients with hepatocellular carcinoma, including those with small solitary tumors.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website